Attached files
file | filename |
---|---|
10-K - 10-K - Mirati Therapeutics, Inc. | mrtx-20201231.htm |
EX-10.36 - EX-10.36 - Mirati Therapeutics, Inc. | townecentredrive-seventh.htm |
EX-10.16 - EX-10.16 - Mirati Therapeutics, Inc. | mrtx-20201231xex1016.htm |
EX-32.1 - EX-32.1 - Mirati Therapeutics, Inc. | mrtx-20201231xex321.htm |
EX-23.1 - EX-23.1 - Mirati Therapeutics, Inc. | mrtx-20201231xex231.htm |
EX-4.5 - EX-4.5 - Mirati Therapeutics, Inc. | mrtx-20201231xex45.htm |
EX-10.37 - EX-10.37 - Mirati Therapeutics, Inc. | employmentagreement-danfag.htm |
EX-31.2 - EX-31.2 - Mirati Therapeutics, Inc. | mrtx-20201231xex312.htm |
EX-31.1 - EX-31.1 - Mirati Therapeutics, Inc. | mrtx-20201231xex311.htm |
EX-10.38 - EX-10.38 - Mirati Therapeutics, Inc. | employmentagreement-benhic.htm |
Exhibit 21.1
Subsidiary | Country of Origin | |||||||
MethylGene Inc. | Canada | |||||||